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Abstract
We present arguments for an evolution in our understanding of how antioxidants in fruits and
vegetables exert their health-protective effects. There is much epidemiological evidence for
disease prevention by dietary antioxidants and chemical evidence that such compounds react in
one-electron reactions with free radicals in vitro. Nonetheless, kinetic constraints indicate that in
vivo scavenging of radicals is ineffective in antioxidant defense. Instead, enzymatic removal of
non-radical electrophiles, such as hydroperoxides, in two-electron redox reactions is the major
antioxidant mechanism. Furthermore, we propose that a major mechanism of action for nutritional
antioxidants is the paradoxical oxidative activation of the Nrf2 (NF-E2-related factor 2) signaling
pathway, which maintains protective oxidoreductases and their nucleophilic substrates. This
maintenance of ‘Nucleophilic Tone,’ by a mechanism that can be called ‘Para-Hormesis,’ provides
a means for regulating physiological non-toxic concentrations of the non-radical oxidant
electrophiles that boost antioxidant enzymes, and damage removal and repair systems (for
proteins, lipids, and DNA), at the optimal levels consistent with good health.
1. Preface
Here we present arguments for the mechanism of action of nutritional antioxidants that are
both a synthesis of evolving ideas that better explain almost all so-called ‘antioxidants,’ and
a refutation of the concept that unselective supplementation can be useful. Our thesis is
written from an historical perspective in order to enhance the foundations for our proposal of
‘Nucleophilic Tone’ and ‘Para-Hormesis,’ and in an attempt to make these concepts (which
are supported by extensive chemical evidence) more accessible to the general reader. We
admit to the drawbacks of diminished comprehensiveness and a bias engendered by our
involvement for 40 or more years in the field. We also apologize to anyone who feels their
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work should have been cited here, but note that this applies to thousands of important
publications that could not all be included.
2. Introduction
The dawn of agriculture, approximately 10,000 years ago, was a major achievement in
human evolution, which resulted in easier availability of metabolic energy from
carbohydrates, fats and proteins. In the first half of the last century, studies on metabolism
and bioenergetics led to the identification of inorganic and organic compounds, including
vitamins, not directly required for energy, but nevertheless indispensable for life. Analysis
of deficiency syndromes, by nutritionists, provided the scientific information that today still
drives recommendations for prevention of specific diseases directly caused by inadequate
intake of specific nutrients. Of course, it was recognized long before the scientific era that
the vegetal kingdom also provides a large number of molecules that act as poisons and/or
drugs in addition to being a major source of metabolic energy and essential vitamins.
In recent decades, however, a view has emerged about another important impact of nutrition
on health. It became clear that many fruits and vegetables contain phytochemicals that may
reduce the risk of diseases [1–3], without being related to any specifically defined
pharmacological effect or deficiency syndrome. This opinion, first suggested by folk
traditions about healthy diets and non-conventional medicine, has frequently been
corroborated by epidemiological/statistical evidence of decreased relative risk of various
diseases. Animal and in vitro studies of specific phytochemicals have often supported such
views.
A major outcome of all this information is the popular recommendation about the
importance of a regular intake of fruits and vegetables to minimize the risk of degenerative
diseases and cancer [4]. The fact that just a minimal, if any, lowering of risk can be observed
in subjects adopting a diet optimized [5] according to the major guidelines, does not limit
the relevance of the issue. Instead, such evidence suggests that it is the non-optimal intake
that leads to an increased risk of disease. As an example, the concept of cancer prevention,
and possibly reversion, by phytochemicals present in fruit and vegetables is usually
discussed with regard to the alleged antioxidant effect brought by a plethora of antioxidant
compounds present in vegetal foods [6].
In this review, we describe how redox prone ‘antioxidant’ phytochemicals present in fruits
and vegetables affect cellular signaling increasing the protective effects of the Nrf2/EpRE
pathway that results in a more reductive/electrophilic environment, which we refer to as
‘nucleophilic tone.’ On the basis of available chemical and biological data we propose that
‘antioxidants’ present in fruit and vegetables paradoxically act together to produce an
additive increase in electrophilic signaling that results in the induction of protective phase II
enzymes and increased nucleophilic substrates, such as glutathione, thioredoxin and
NADPH. Furthermore, such nucleophilic substrates are all maintained in a reduced state
through increased pentose shunt utilization of glucose. Our ‘Nucleophilic Tone’ concept
contrasts markedly with the kinetically unrealistic free radical scavenging proposal that has
dominated ‘antioxidant’ discussions for several decades.
3. A brief history of antioxidants
First, we will review how antioxidants became synonymous with free radical scavenging,
and how kinetic constraints limit the ability of free radical scavenging to explain dietary
antioxidant actions, with the notable exception of vitamin E.
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The first semi-empirical use of antioxidants was in the 19th century when several molecules
were used to control the process of rubber production and to prevent ‘fatigue’ of the
polymers [7]. Soon, the same or similar molecules were introduced in the food industry to
prevent rancidity, the most marked outcome of oxidative degradation of stored foods [7].
The chemistry underlying these effects is the quenching of peroxyl radicals and the
reduction of hydroperoxides. The most typical examples of compounds acting through these
two mechanisms, quenching of free radicals and reduction of electrophiles, are natural or
synthetic phenolic compounds and sulfite, respectively.
In the first half of the 20th century, studies on the chemistry of oxidation of organic
molecules and the involvement of free radical intermediates led to the generalization by
Michaelis (best remembered for his famous description of enzymatic kinetics) that ‘all’
biological oxidations involved free radicals [8]. While this (rather extreme) proposal was
subsequently refuted, a consensus was reached that a significant number of biological
oxidations (catalyzed by enzymes) do indeed involve the formation of free radical
intermediates [9]. Interest in the biological significance of free radical chemistry led Albert
Szent-Györgyi (Nobel laureate for the discovery of various Krebs cycle intermediates and
vitamin C) to elaborate the concept that incorrect free radical formation or elimination is the
ultimate cause of cancer [10]. The free radical in cancer problem, which Szent-Györgyi
characterized as “an electronic problem” led him to describe life as having negative entropy
or ‘syntropy’ [11]. The concept of ‘syntropy’ is therefore an evolution of the concept of
negative entropy introduced by Erwin Schrödinger (also a Nobel laureate), in defining life
using quantum physics [12].
During their lifetimes, experimental science did not provide evidence to support the radical
hypotheses of Michaelis and Szent-Györgyi. Nevertheless, the concept that free radical
chemistry participates in biology was progressively formulated and consolidated.
Ultimately, it was concluded that radicals produce cellular damage and that eliminating free
radicals must, therefore, be health protective. The free radical theory of aging by Denham
Harman, following on observations by Rebecca Gershman in radiation biology [13] (see
below) is the most relevant example of this trend in scientific thought [14]. Eventually, as
described in the next section, some ‘good’ uses of free radicals were discovered. These
contributed to the generally accepted idea of today, that free radicals are part of normal
physiology but that poorly controlled production causes damage [15]. Thus, it seemed a
perfectly reasonable conclusion that scavenging harmful free radicals with supplemental
‘antioxidants’ would be health protective and promote a healthy, perhaps longer, life.
Awkwardly for the field, the concept of free radical scavenging by supplemental
antioxidants has been challenged at least in higher animals and in human clinical trials [16–
19]. Nonetheless, demonstrations of free radical scavenging in test tube measurements and
animal and cell culture experiments of imposed oxidative stress, contributed to the
popularity of the unproven concept that free radical scavenging antioxidants protect health
and possibly prolong life. The exception appears to be high dose α-tocopherol, at least in
prevention of cardiovascular disease [20].
Protection by various antioxidants (or, better, diets containing antioxidants) against different
chronic diseases and cancer has been attributed to their antioxidant capacity [21]. But as this
does not fit kinetic data, there must be an epistemological error. Our main intent then is to
explain how dietary antioxidants, effective in providing health protection, do not, with the
exception of vitamin E, act just as free radical scavengers. We will then go on to explain
how ‘antioxidant’ phytochemicals paradoxically act through cell signaling to maintain
‘Nucleophilic Tone’ involved in enzymatic antioxidant protection. We define Nucleophilic
Tone as the capacity to remove electrophiles through enzyme catalyzed, dynamic flow of
reducing equivalents from NADPH, GSH and reduced thioredoxin. In other words,
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Nucleophilic Tone is the overall potential cellular adaptive response to oxidative challenge
brought by electrophiles.
4. Free radicals and oxygen
In the early fifties, the rapid development of nuclear energy was accompanied by a
realization of a need for chemoprevention of radiation damage. This seemingly motivated
studies by Rebecca Gershman and Dan Gilbert that resulted in a ground breaking
achievement [13]. They showed that radiation damage is largely enhanced by oxygen.
Ionizing radiation produces free radicals while oxygen, by reacting with free radicals,
propagates biological damage through chain reactions.
The mechanism necessitating the involvement of free radicals depends on the peculiar
electronic distribution of di-oxygen, which in the ground state has a triplet spin status due to
the fact that its two unpaired electrons have the same spin state [22]. The direct interaction
of ground state di-oxygen with carbon, which has a singlet status (all electrons paired), is
prevented by the extremely high activation energy caused by the need for one of two
unpaired electrons to flip its spin in order to become the reactive (excited but non-radical)
species, singlet oxygen. The energy to produce singlet oxygen is rarely found in biological
systems outside of photo-oxidation catalyzed by exogenous agents.
This ‘spin restriction’ explains the kinetic sluggishness of di-oxygen in oxidizing organic
compounds even though such reactions have a high thermodynamic potential. Lowering the
activation energy occurs when redox transitions take place by single electrons, as in the
reaction of carbon-centered free radicals with triplet di-oxygen [23]. Understanding that
radiation involved free radicals further contributed to the wishful thinking that free radical
scavengers would protect against oxidative damage. Moreover, the addition of di-oxygen to
a free radical produces a hydroperoxyl radical that primes oxidative chain reactions of lipid
peroxidation (see below).
Unfortunately, while many organic compounds react with free radicals with high rate
constants (see below), a compound that can protect humans against free radical damage
from ionizing radiation has never been discovered. Indeed, since almost all biologically
relevant molecules can react with the most reactive free radicals at similar rates, it is
reasonable to assume that no miraculously effective antioxidant will ever be found. Later in
this review, we will deal with so-called hydroxyl radical scavengers, an extreme case of
wishful thinking. Regardless, the sole mechanism that has been reported to reduce
carcinogenesis in animals exposed to ionizing radiations is previous exposure to low-level
radiations, which likely works through enhancing DNA repair and adaptive defense
mechanisms [24, 25]. Although still a matter of debate, such protection stresses the
relevance of biological adaption (or hormesis) to oxidative stress, where endogenous
defenses are activated to provide increased protection against subsequent stress challenges
[26–28]
5. Discoveries of superoxide dismutase (SOD), the respiratory burst and
production of superoxide by mitochondria. First evidence of in vivo
production, and protection against oxidative damage involving a free
radical
Appreciation of the relevance of free radicals in biology received a major burst in the early
1970’s with the discoveries of multiple forms of SOD by Irwin Fridovich [29–32], the
NADPH oxidase (respiratory burst) by Bernard Babior [33] and the demonstration that
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production of hydrogen peroxide, first described by Britton Chance, was actually preceded
by superoxide production [34, 35]. Knowing that superoxide is physiologically produced by
either an enzymatic system for a biological purpose or by a leak of electrons from the
respiratory chain, and that enzymes evolved to be competent for its removal, clearly framed
the ‘respectability’ of the new field of free radicals in physiology and pathology. Indirectly,
these discoveries also contributed support for the paradigm that scavenging free radicals, at
least in some conditions, had to be a suitable mechanism for protecting health [36]. Since
these pioneering studies were published, it has also become abundantly clear that not all
oxidants are actually scavenged in vivo, and that oxidative damage to proteins, lipids, and
DNA is a fact of daily life. Of course, we have also learned that cells are protected by
secondary and tertiary layers of damage removal and repair systems (e.g. proteinases,
lipases, DNA repair enzymes) that help to make life in an oxygen-rich environment possible
[37–39]
6. The carbon tetrachloride story (role of hydroperoxyl radicals and vitamin
E): First example of an experimental pathology prevented (and cured) by an
antioxidant inhibiting lipid peroxidation
In the molecular toxicology area, discovery of the mechanism of carbon tetrachloride
toxicity (and halogenated compounds in general) by the teams of Recknagel, Burton, Slater,
and Dianzani [40, 41] bridged a relevant gap between toxicity, free radicals and protection
by antioxidants. When ingested, halogenated compounds are decomposed by microsomal
cytochromes generating carbon centered radicals. These, like radicals produced by radiation,
react with oxygen producing hydroperoxyl radicals that initiate and propagate oxidative
chain reactions in the lipid phase. This pathological event can be fully prevented, and in
some conditions cured, by α-tocopherol [42]. To us, this is the most remarkable evidence
that at least one physiological function of vitamin E is the inhibition of lipid peroxidation.
The molecular mechanism of carbon tetrachloride toxicity was rapidly and fully integrated
with the growing knowledge on lipid peroxidation. The oxidative degradation of fats
exposed to air was first described by De Saussure an the end of 18th century [43] and some
chemical clues as to mechanism were then added by Antoine Parmentier [44] the French
Pharmacist who studied oxidation of oils and became incorporated into the history of the
invention of ‘French fries.’ Rancidity, of course, had been known for centuries but the role
of oxygen and detailed understanding of the reactions involved was achieved only in the
second part of the 20th century. Semantically, air oxidation of fats is named autoxidation,
while a similar event, when catalyzed in living biological material is referred to as lipid
peroxidation. In the original formulation by Hochstein and Ernster [45], microsomal lipid
peroxidation is initiated by the reduction of a transition metal (usually iron) which in turn is
able to form complexes with oxygen that are competent in the extraction of a hydrogen atom
from a polyunsaturated lipid in membranes [46]. The alternative, and likely more efficient
mechanism of initiation is the decomposition of a lipid hydroperoxide in the presence of a
reduced transition metal, forming an alkoxyl radical that is extremely effective in extracting
the hydrogen atom from a polyunsaturated lipid [47].
Lipid peroxidation then proceeds through a chain reaction that is seemingly the same as for
initiation by radiation or decomposition of halogenated compounds. The carbon centered
radical reacts with oxygen producing a lipid hydroperoxyl radical, in turn extracting a
hydrogen from another lipid and forming a lipid hydroperoxide and a carbon centered
radical. Both autoxidation of lipids and lipid peroxidation are cyclic events where, from a
single initiation, a chain reaction starts that is limited only by reagent availability and
radical-radical termination reactions. Lipid peroxidation is inhibited by phenolic
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antioxidants quenching lipid radicals propagating the chain reactions, and by reduction of
lipid hydroperoxides from which radicals are continuously generated [47]. It is noteworthy
that in biology this concerted interplay between antioxidant scavenging hydroperoxyl
radicals and enzymatic reduction of hydroperoxides fully overlaps the synergy between free
radical scavengers and ‘peroxidolytic’ compounds in polymer chemistry [7].
7. How the terms ‘free radical scavenger’ and ‘antioxidant’ become
synonymous
The scientific achievements briefly summarized above, contributed to substantiation of the
syllogism, which states that, since free radicals produce damage and antioxidants scavenge
free radicals, antioxidants must be health protective because they quench free radicals. Thus,
it was presupposed that the more antioxidants one could pack into cells and tissues, the
greater would be the resistance to pathology caused by free radicals. This syllogism
subsequently primed the development and implementation of measurements of the capacity
of both pure phytochemicals and biological samples to quench free radicals. Such studies
have flooded the scientific literature for the past two decades. In these experiments, different
radicals produced in vitro are reacted with molecules present in the sample under scrutiny.
One can then measure either the extent to which radicals are ‘quenched’ or the kinetics of
the oxidation of a reporter molecule, as altered by the ‘antioxidant’ under study. By such
methods, both biological samples and thousands of phytochemicals have been shown to
have ‘significant’ free radical scavenging antioxidant capacity.
Unfortunately, no major insight into whether radical scavenging actually accounts for a
decrease in pathology due to antioxidants (except by SOD and vitamin E) has emerged from
the enormous amount of data generated to date. The most reasonable reasons for this
apparent failure are: (1) The analytical systems used by researchers were markedly different
from the conditions actually extant in vivo. Free radicals have generally been produced for in
vitro studies at much greater rates than would be observed in realistic physiological or even
pathological conditions (aside from exposure to lethal radiation); (2) As illustrated by
examples in the next section, the most reactive free radical will react with approximately the
same rate constant with many low molecular weight antioxidants and the biological
molecules (proteins, lipids, DNA, etc.) to be protected. Thus, most candidate antioxidant
compounds have no advantage over any others in terms of rate constant. Concentration is, of
course, the other contributing factor to the rate of radical reactions but, with the exception of
vitamin E and the endogenous antioxidant glutathione, the concentrations that can be
achieved in vivo cannot overcome the kinetic limitation; (3) Quenching a given free radical
in vitro does not necessarily translate into having an antioxidant effect in vivo. Although
concentration and rate constant figure into this issue as well, the location of free radical
production versus where antioxidants may ultimately localize within cells and tissues can
also be a major factor in limiting in vivo effectiveness.
8. Can free radicals be efficiently scavenged under biological conditions?
a. Hydroxyl and alkoxyl radicals – Why we need enzymes instead of free radical
scavengers
The rate of an antioxidant-oxidant reaction, which would be a second order reaction, is
determined by the equation, Reaction rate = k[A][B], where k is a second order rate
constant, [A] is the concentration of the antioxidant, and [B] is the concentration of the
reactive species.
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The hydroxyl radical is produced by radiolysis of water or decomposition of hydrogen
peroxide. This extremely reactive radical reacts with practically all molecules present in a
cell with a rate constant approaching the rate of diffusion limitation [48, 49].
1)
It is therefore essentially meaningless to argue that any scavenger could be protective by
reacting with hydroxyl radical. Unfortunately, the literature is filled with reports of the latest
and greatest hydroxyl radical scavenger, often discovered in an exotic fruit or vegetable.
The same argument against effective scavenging by any particular molecule holds for
alkoxyl radicals produced by decomposition of lipid hydroperoxides, which occurs mainly
in membranes [50, 51].
2)
For both these similar radicals the only efficient protection mechanism is to prevent their
formation rather than trying to scavenge them after they are formed. Such prevention in vivo
is by reduction of H2O2 to water, or reduction of lipid hydroperoxides to their corresponding
alcohol [47, 52] and these antioxidant reactions are enzyme-catalyzed. While catalase can
dismutate H2O2 to H2O and O2, peroxidases and peroxiredoxins reduce hydroperoxides
using the endogenous electrophiles, glutathione (GSH) or thioredoxin (Trx) [53]. Reduction
of these sulfur-containing substrates is maintained primarily by NADPH derived from the
oxidation of glucose in the pentose shunt, which (one could argue) eventually emerges as the
ultimate antioxidant.
b. Carbon centered and hydroperoxyl radicals - The special case of vitamin E explained
A carbon-centered radical is produced when a reactive oxidant radical extracts a hydrogen
atom from a C-H bond. In the presence of O2 this initiating radical next produces a
hydroperoxyl radical [54, 55]:
3)
Reaction 3, which escapes the spin restriction, is also extremely fast and its inhibition can be
achieved in extremely anaerobic conditions, such as packages for long-term food storage,
but such conditions are hardly pertinent to aerobic living systems.
Once the hydroperoxyl radical is formed from a lipid molecule, a chain reaction is initiated.
This event is peculiar to the ordered structure of membrane monolayers [51, 54]. The radical
is indeed reduced to a lipid hydroperoxide in a relatively slow reaction by another lipid that
is prone to oxidation, such as those containing a polyunsaturated fat having allylic carbons
on which a new carbon centered radical is generated.
4)
Repetition of reactions 3 and 4 produces a chain that can be interrupted by consumption of
the limiting reagent, or by radical-radical interaction (an ‘annihilation’ reaction).
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Lipid hydroperoxides formed can undergo reductive decomposition generating alkoxyl
radicals that are competent for the initiation of new chains of reaction, starting from reaction
2 [56].
As mentioned above, reduction of hydroperoxides catalyzed by peroxidases using GSH or
Trx prevents reaction 2. A suitable non-enzymatic antioxidant mechanism based on free
radical scavenging is only possible with respect to the relatively slow reaction 4 [54].
In fact, hydroperoxyl radicals react with a fast rate constant with phenolic compounds. The
most typical, and possibly biologically relevant and specific phenolic ‘antioxidant’ is α-
tocopherol (T-OH in reactions 5, 6, and 7), which is transported into the liver by a specific
carrier where it is incorporated into HDL that then transfers it to other lipoproteins and then
to other tissues.
5)
This reaction is referred to as chain breaking, since the reactivity of the α-tocopherol radical
(T-O• in reactions 5, 6, and 7) is much less than that of other radicals (reactions 2 and 4)
[51]; i.e., the α-tocopherol radical is ‘ relatively stable’ and the subsequent reaction 6 is very
slow [57].
6)
However, a corollary of this evidence is that, under specific conditions, the generation of an
α-tocopheroxyl radical; e.g., by electron transfer to a metal ion, can indeed generate a lipid
radical and thus slowly initiate lipid peroxidation [57, 58]. Far from being paradoxical, this
event is fully consistent with the kinetics of free radical reactions.
The final fate of the α-tocopheroxyl radical is the eventual oxidation to a stable non-radical
quinone by a second oxidation or by dismutation of the radical species. Also a reduction
back to hydroquinone (recycling) is kinetically favorable and the seemingly most efficient,
biologically available, reductant is ascorbate (Vitamin C) [59]:
7)
The rather unreactive ascorbate radical may be eliminated by dismutation or by reduction
with NADH catalyzed by ascorbate radical reductases found in the cytosol, or by the
membrane-bound NADH-cytochrome b5 reductase activities reported in mitochondria,
microsomes and plasma membranes [60–64].
In conclusion, kinetic data indicate that an efficient antioxidant protection is carried out only
by the synergistic interplay between: (a) the 2-electron reduction of hydroperoxides and (b)
the 1-electron reduction of hydroperoxyl radicals [47].
c. Potential of glutathione as a radical scavenger – sink or sinker?
The nucleophile GSH is the major substrate of peroxidases reducing hydroperoxides but it
can also be a direct free radical scavenger. Indeed, the generation of a sulfur-centered radical
in the presence of different oxidizing radicals is likely also in light of the high GSH (1–10
mM) concentration in cells. This radical initiates an electron sink pathway proposed by
Winterbourn [65] through which electrons are eventually transferred to oxygen forming
superoxide, which is very rapidly dismutated by SOD.
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This electron sink hypothesis argues for a role of GSH as a valid free radical scavenger and
SOD as the final antioxidant enzyme [65]. Although the sink hypothesis is kinetically and
thermodynamically feasible [66], the sulfur centered radical can also react rapidly with
oxygen producing species that could be competent for other, possibly damaging, reactions
[67].
11)
Evidence for either protection or damage through these reactions is however, unavailable.
Thus, while the pivotal role of GSH as a nucleophile in enzyme-catalyzed reactions that
reduce hydroperoxides is unquestionable, it is still unclear whether it could also play a
physiologically relevant role as free radical scavenger.
9. What then, exactly is an antioxidant?
a. Definitions
Having discussed the concept of a free radical scavenger as an antioxidant, for the purpose
of the forthcoming discussion here, it is useful to define what we mean by ‘antioxidants,’
‘oxidants,’ ‘electrophiles,’ ‘nucleophiles,’ and ‘reductants.’ Electrophiles are molecules that
take electrons from other molecules, called nucleophiles. Oxidants are electrophiles that take
one or two electrons from a nucleophile without forming an adduct. Reductants are then
nucleophiles that give one or two electrons to an oxidant, without forming an adduct. The
transfer of electrons in oxidations and reduction may involve a hydrogen atom (H·) in one-
electron reactions or a hydride (H−) in two electron reactions (Fig 1). There are different
functional definitions for the word, ‘antioxidant.’ In chemistry, antioxidants are nucleophilic
reductants that directly react with oxidants, thus preventing the oxidation of a third
molecule.
According to the kinetic constraints discussed above, the antioxidant effect is obtained either
by reducing by a single electron (usually by donating a H), or by preventing the formation of
the initiating hydroxyl or alkoxyl radical (by reducing the hydroperoxide, from which the
initiating radical is generated, to an alcohol). Antioxidants used in polymer chemistry or
food preservation (phenolic and hydroperoxide-reducing compounds) are examples of the
interplay between these two complementary mechanisms [7]
A large number of synthetic compounds and phytochemicals are, indeed, chain-breaking
antioxidants as they form relatively stable radicals, following the extraction of a labile
hydrogen atom by a hydroperoxyl radical. This feature derives from the possibility of
delocalizing the unpaired electron until the molecule is stabilized by either a second electron
extraction or a single electron reduction. This feature most frequently, although not always,
is contributed by the common ortho or para hydroquinone moiety present in vegetal
polyphenols, while meta hydroquinone moieties cannot produce any antioxidant effect
because they cannot form the corresponding quinone. The available evidence, however,
argues against such functions being efficient in vivo. Although the rate constant for the
reaction with hydroperoxyl radicals is in the same range as vitamin E, the concentration of
ortho- or para-quinones reached in cells and in membranes is much lower. Moreover,
vitamin E deficiency syndrome cannot be cured by antioxidants other than authentic vitamin
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E itself. As discussed later, it is possible that when polyphenols are oxidized by reaction
with free radicals, the resulting electrophilic quinones are involved in signal transduction
pathways to activate cellular antioxidant activities and damage removal/repair systems but
this is clearly different from free radical scavenging.
These limitations imposed by bioavailability, concentration and location of phenolic
antioxidants in cells are, however, overcome in some specific cases. An example is in the
lumen of the digestive tract where ingested foods can undergo oxidative degradation,
eventually leading to a post-prandial oxidative stress that is clearly prevented by intake of a
large source of phenolic antioxidants, such as wine, with meals [68].
A common misconception is that ‘antioxidants’ can efficiently reduce hydroperoxides
(ROOH) by a two electron transition, and thus through a non-radical mechanism. While
many compounds, particularly thiols, have reaction rates with ROOH that are fast enough to
be significant in vitro, and perhaps also in the extracellular environment, these reactions can
only make an insignificant contribution to the reduction of ROOH inside cells. This is
because of the slow rate constants of the nucleophilic substitution reaction (SN2). Even if the
concentrations of the purported antioxidant that can be reached in cells or plasma are high,
the reaction rates are insignificant in comparison with enzymatic reactions catalyzed by
various peroxidases and peroxiredoxins [53]. Thus, enzyme-catalyzed reactions using
nucleophilic substrates, rather than non-enzymatic free radical scavenging, usually provide
for biologically relevant antioxidant defenses.
b. The alternative to free radical scavenging - the paradoxical effect of antioxidants
As a free radical scavenger mechanism for nutritional antioxidants cannot be substantiated
on a kinetic basis in vivo, what then accounts for the nutraceutical effect of these
compounds? Studies over several decades (only recently markedly helped by conceiving the
possible underlying mechanism) demonstrate that many of the so-called ‘antioxidants’ in
foods and beverages provide cellular and tissue protection against oxidative damage by
inducing endogenous antioxidant defenses. Thus, a variety of compounds, including
polyphenols, which can act as chemical antioxidants in vitro, actually induce enzymatic
systems in vivo. These enzyme-catalyzed processes in turn alter the steady-state levels of
crucial regulatory and/or protective elements. What is now abundantly clear is that, rather
than acting as chemical antioxidants in vivo, the chemical properties of these ‘antioxidant’
compounds generate signals for the induction of protective enzymes.
It now appears that the chemically important properties of ‘antioxidants’ in vivo are either
pro-oxidant (generating reactive species) and/or electrophilic (having the capacity to form
adducts to proteins). Such, properties are typically associated with toxic substances.
However, we are fortunate that for most of these compounds it is practically impossible to
reach a concentration that is actually toxic. Instead, the concentrations seemingly reached in
vivo are sufficient to cause the activation of signaling pathways in cells that have evolved to
recognize potential threats by sub-toxic concentrations of electrophiles. In this respect, the
limited bioavailability of most ‘antioxidants’ is definitely a fortunate and appropriate
characteristic, rather than a limitation that must be overcome in order to provide greater
protection.
The explosion in recombinant DNA technology in the last three decades also provided
powerful new tools to solve the antioxidant conundrum. Early investigators, having in mind
a possible homeostatic equilibrium, expected that by increasing (exogenous) antioxidant
capacity, nutritional phenolic antioxidants would cause a decrease in endogenous
antioxidant protection through feedback inhibition of regulatory mechanisms. Instead,
investigations showed that phenolic compounds, along with isothiocyanates and some other
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phytochemicals, actually produced an increase endogenous antioxidant protection. This
ability to induce antioxidant enzymes and increase their substrates through signal
transduction pathways leading to altered gene expression, particularly for the Nrf2 (nuclear
factor erythroid 2-related factor 2) pathway, is the focus of the next section.
10. Nrf2/ARE/EpRE (Nuclear factor erythroid 2-related factor 2/Antioxidant
Response Element/Electrophile Response Element)
a. Discovery of Nrf2 and EpRE (along with its unfortunate ARE misnomer)
Nrf2 is a member of the Cap’n’collar transcription factor family that includes SKN-1 in C.
elegans and CncC in Drosophila. Activation of the Nrf2 transcription factor and the
electrophile response element, EpRE (also called the antioxidant response element or ARE)
to which Nrf2 binds [69–79] are key in adaptive responses to various oxidative stimuli [80,
81]. Studies demonstrating that phytochemicals present in vegetables acted in cancer
chemoprevention by inducing what are called phase II enzymes [82] and how some planar
aromatic compounds, initially thought to act as ‘free radical scavenger antioxidants’ also
induced these enzymes led to the discovery of the Nrf2/EpRE signaling system. As part of
his pioneering work on chemoprevention, Talalay and his coworkers [82] demonstrated that
several compounds that induced the Phase II enzymes had to be metabolized to electrophilic
compounds in order to function. Over the next few years, the central mechanism through
which these electrophilic compounds act was revealed. More than twenty years later,
however, this is still an evolving story.
The discovery of Nrf2, the transcription factor regulating expression of most Phase II and
some Phase III genes, resulted from a search for the proteins that activated the cis element to
which Nrf2 binds. That cis element was first described by Rushmore, Pickett and their
colleagues [83] as the antioxidant response element (ARE) because planar aromatic
compounds that were identified as antioxidants were able to activate the transcription of
genes for Phase II detoxification enzymes. But, at the same time Daniel and coworkers [84]
demonstrated that electrophiles and only metabolites of planar aromatic compounds that
were metabolized to become electrophiles could activate a cis element they named the
electrophile response element (EpRE). Shortly thereafter, Rushmore et al. [85] showed that
H2O2 and redox cycling phenolic compounds that generate H2O2 could activate the ARE.
Of course phenolic compounds are the metabolic products of the planar aromatic
compounds and the quinones formed as part of the redox cycling are electrophiles. The next
year, it became clear that the unfortunately named ARE and accurately named EpRE are the
same 9 base consensus sequence [86] targeted by Nrf2.
As the EpRE consensus sequence contains tandem TRE or TRE-like sequences, it was
initially suggested that the EpRE was activated by the binding of two AP-1 transcription
factors composed of c-Jun/c-Fos dimers [86]. But the key transcription factor that binds to
EpRE in response to electrophiles, Nrf2, was first described as a transcription factor that
bound to tandem repeats of the consensus sequence for the transcription factors AP1 and
NF-E2 (activating protein 1 and nuclear factor erythroid 2, respectively) in the β-globin
enhancer region although it was clearly not identical to NF-E2 [87]. Nrf2 is therefore also
known as NF-E2-related factor 2. In 1996, the first connection was made between Nrf2 and
EpRE (called ARE in that work) [88]. This was soon confirmed by others [89].
In their seminal paper, Venopal and Jaiswal also showed that Jun proteins are activating
partners of Nrf2 [90] while c-Fos and Fra1 are negative regulators of EpRE activation [88].
There remains controversy concerning the partners of Nrf2 as some suggest that the small
Maf proteins are the partners [91] whereas others have suggest that Maf proteins are either
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inhibitors or place holders that are displaced by Jun proteins when Nrf2 binds to EpRE [78,
92]. In a recent publication, it has been shown that the N-terminal phosphorylation of c-Jun
can negatively or positively affect EpRE-dependent transcription in a both a gene- and cell
type-dependent manner [93]. This finding contrasts with the well-established requirement
for c-Jun N-terminal phosphorylation to be active in promoting transcription when part of
the AP-1 complex is bound to the TRE element.
b. Keap1 and its regulation of Nrf2 activation
A few years after the discovery of Nrf2, the protein to which it binds, Keap1 (Kelch-like
ECH-associated protein 1), which is a homolog of the Drosophila actin-binding protein
Kelch, was described by Itoh et al. [94], who proposed that Nrf2 is retained in the cytosol
until Keap1 is modified by electrophiles. Keap1 is also called INrf2, for inhibitor of Nrf2, a
less common but more descriptive name [95]. While activation of Nrf2 requires
modification of Keap1, It was later found that Keap1 does not just simply retain Nrf2.
Rather, Keap1 causes the rapid turnover of the Nrf2 transcription factor by assisting in Nrf2
ubiquitinylation (resulting in rapid degradation by the 26S proteasome) [94]. When critical
cysteine residues in Keap1 are oxidized or covalently modified, Keap1 is inactivated and the
Nrf2 transcription factor half-life is extended [96] (Fig 2).
Further investigation has shown that, although addition of exogenous H2O2 can activate
Nrf2 by causing disulfide formation between two Keap1 molecules [97], it is the alkylation
of critical cysteine residues on a single Keap1 molecule by non-toxic concentrations of
electrophiles that allow Nrf2 to escape degradation. Exactly which of the 27 cysteines in
Keap1 are effected by alkylation appears to depend upon both the particular electrophile and
its concentration [98–103]. The Keap1 cysteine residue that is most reactive to sulforaphane
is Cys489 [99], while Cys273 and Cys288 are the most reactive toward the model alkylating
agent, dexamethasone mesylate [98]. Also, as pointed out above, the planar aromatic
compounds that were shown to require redox cycling in order to activate Nrf2, form
electrophilic quinones during redox cycling. Thus, it may be the quinone rather than the
H2O2 formed during redox cycling that is the actual Keap1 modifier.
c. Further aspects of Nrf2 regulation
Although a key aspect of Nrf2 activation is its escape from ubiquitinylation and proteasomal
degradation, Nrf2 must also be phosphorylated for translocation to the nucleus where it
activates EpRE-regulated genes [104, 105]. The protein kinases, PKCδ, and Akt, involved in
the phosphorylation and translocation of Nrf2, are also activated by oxidants and other
electrophiles [106–110]. Thus, Keap1 modification, although essential, is not the only
reaction involved in the activation of Nrf2 signaling by electrophiles.
While inactivation of Keap1 and Nrf2 phosphorylation are major factors in the activation of
EpRE-regulated transcription other studies have indicated the importance of Nrf2/EpRE
regulation by transcription factors that partner with Nrf2 in binding to EpRE (Mafs G/F/K
[111], JunD [78, 112], c-Maf [92], c-Jun [90], c-Fos and Fra1 [88]) and transcription factors
that compete with Nrf2 for binding to EpRE (Bach1 and Nrf1) [113]. Furthermore p21
increases the stability of Nrf2 [114] while c-Myc apparently accelerates Nrf2 degradation
and inhibits Nrf2-dependent transcription by binding to it at EpREs [115]. Regulation of
Nrf2 is also involved in its dissociation from EpREs and subsequent proteolytic degradation
[116]. The potential role of redox signaling or involvement of phytochemicals in these
aspects of Nrf2 regulation remains largely unexamined.
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11. The endogenous antioxidant system
With the possible exception of the electron sink describe above, and the actual exception of
SOD, physiological antioxidant defense does not entail free radical scavenging. Different
forms of SOD catalyze, through redox shuttling of Cu or Mn (and Fe in microbes and
plants), the dismutation of O2·−, which is constantly produced in cells. This results in
production of H2O2, which is then dismutated by catalase to H2O and O2 or reduced to H2O
by various peroxidases. SODs are antioxidant enzymes in relation to the removal of O2·−,
that is indeed more a reductant rather than an oxidant unless protonated (pKa 4.7) [117]. On
the other hand O2·− reacts with ·NO, producing the strong oxidant peroxynitrite [118], or
with ferric iron complexes releasing the ferrous iron that reductively decomposes
hydroperoxides to generate extremely reactive radicals [7].
Rather than generic free radical scavenging, the reduction of hydroperoxides, and
electrophiles in general, emerges as the critical antioxidant mechanism adopted by
mammalian cells. Apparently, the synergistic interplay between chain breaking free radical
scavengers and peroxidolytic compounds originally defined in polymer chemistry, applies
also in living cells, where the nutritionally essential α-tocopherol works as a chain breaker
(1 e− transition) and different nucleophiles eliminate, in enzymatic reactions, the
electrophilic hydroperoxides (2 e− transition).
Nucleophilic compounds bearing thiol groups (-SH), primarily GSH and thioredoxin reduce
electrophiles in SN2 nucleophilic substitution reactions. The oxidized forms of the electron
donors (usually disulfides), are then reduced back by hydride (H−) transfer from NADPH.
Of course, NADPH is produced primarily in the pentose shunt pathway making glucose the
ultimate source of electrons for antioxidant reactions in cells. The reduction of electrophiles
is catalyzed by Se/S peroxidases or peroxiredoxins and reductases, again using Se or S as
redox moieties linked to a flavin redox center and NADPH as the H− donor. Although heme-
iron is used in catalase, the larger part of the physiological antioxidant mechanism is the
domain of the redox chemistry of chalcogens (S and Se).
12. Inflammation, oxidative signaling and nucleophilic response
Living organisms are continuously exposed to harmful chemical, physical and biological
stimuli challenging cellular, tissue, organ, and organismal homeostasis. According to the
concept of milieu intérieur proposed by Claude Bernard, in which both metabolites and
macromolecules remain within a physiologically range, ‘disease’ is seen as a permanent
alteration of homeostasis [119]. This range is actually very far from thermodynamic
equilibrium, which occurs only after death. All organisms evolved mechanisms for
counteracting damaging stimuli that alter homeostasis by repairing damage or eliminating
irreversibly damaged cells, the survival of which could be risky for the organism.
The reaction to agents that produce injury varies with the ability of particular cells to prevent
or repair damage and the amplitude of the response extends over a large range [120]. The
basic elements of inflammation consist of an array of reactions addressed to elimination of
the stimulus, repair of tissue through cell proliferation and angiogenesis, and elimination of
the most damaged cells. Remarkably, practically all of these events are orchestrated by a
series of crucial cell signaling pathways, many of which operate through oxidation of
peptide/protein sensors that function as transducers or effectors of the signal [121]. Under
normal physiological conditions, this oxidation of peptide/protein sensors, which are
necessarily by far more sensitive to oxidation than are other proteins, takes place without
cell injury. In a general view, response to injury and inflammation evolves with the
formation of electrophiles, including oxidants that produce a second level of signaling
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mimicking the physiological response but also accompanied by a persistent alteration of
homeostasis with elevated levels of oxidized metabolites and macromolecules. These
deviations from redox homeostasis are often cumulatively referred to as ‘oxidative stress.’
Inappropriate, excessive or prolonged physiological response to a given challenge, a
condition comprehensively described as stress, leads to the stable alteration of homeostasis
we perceive as disease. In this view, quite different diseases, such as cancer,
neurodegeneration, liver and lung fibrosis, etc., can all be seen as examples of inappropriate
or poorly controlled activation of the mechanisms of response to injury, irrespective of
whether the actual injury exists or not. Uncontrolled proliferation and resistance to apoptosis
are hallmarks of cancer [122] while cell death predominates in chronic degenerative diseases
[123]. A common element in both groups of diseases, however, is an aberrant activation of
defense and healing mechanisms, taking place through uncontrolled oxidative signaling and
damage evolving into an ‘oxidative stress’.
The paradigm of a physiological function mimicked in epithelial cell carcinogenesis is
wound healing, where inflammation, cell proliferation, angiogenesis, epithelial-
mesenchymal transition, and escape from apoptosis are activated. Indeed, these events
impressively overlap the hallmarks of cancer where the phenotype is stabilized by mutations
of specific genes [122]. In this respect, the shared crucial common motif in cell signaling, is
the formation of redox signaling molecules (H2O2, lipid hydroperoxides, α,β-unsaturated
carbonyls, and possibly other electrophiles) that activate a series of redox switches through
oxidation of specific cysteine residues [121, 123]. Beyond Keap1, which is possibly the
most sensitive, these switches are frequently nuclear factors or protein kinases and
phosphatases that integrate redox signaling with protein phosphorylation [121]. Other redox
signaling includes effects on calcium pumps and phospholipases [124, 125]
13. Nucleophilic Tone & Para-Hormesis versus radical scavenging
antioxidants
As a common motif of stress related signaling is oxidative in nature; i.e., formation of
electrophiles, it follows that homeostasis for ‘Nucleophilic Tone’ must also entail
counteracting mechanisms for switching off the production of (excess) electrophiles. This
encompasses the synthesis of nucleophiles, namely GSH and different redoxins, the specific
reductases of the oxidized forms, and the supply of reducing equivalents from NADPH by
glucose oxidation. But central to the regulation of Nucleophilic Tone is the activation of
Nrf2 through the modification of Keap1 by electrophiles.
In the “Omnivore’s Labyrinth,” [3] phytochemicals produced in the vegetal world are
exported to animal world where they contribute to maintenance of health. For ‘inadequate’
intake of these compounds there is not a specific deficiency syndrome as there are for
vitamins. Rather, there is an increased risk of disease that is much more difficult to
demonstrate unequivocally. It follows that, although optimal nutrition minimizes the risk,
supplementation to levels that exceed saturation of the Nrf2 activation system will hardly
exert any beneficial effect. This concept, however, does not exclude the possibility that
innovative more efficient drugs may be designed using bimolecular recognition as the
template for interactions of nutraceuticals with other specific biological targets.
This idea of a positive, although dispensable, effect of phytochemicals is elegantly exploited
in the concept of xeno-hormesis introduced by David Sinclair: molecules synthesized by
plants to counteract stress can work similarly in animals using those plants as food [126].
From a survey of the enormous literature suggesting that natural compounds can have
nutraceutical effects, and from studying those compounds recognized as healthy by folk
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traditions in different areas of the world, a leitmotif comes to light relative to the control of
inflammatory reactions and protection against chronic degenerative diseases [2] and cancer
[6, 127]. Apparently, these heterogeneous effects are related by control of cell reactivity
against inflammatory stimuli [6]. This can be achieved by inhibition of NADPH oxidases
from which O2·− is produced, or NF-κB, or by an increase of Nucleophilic Tone primed by
modification of the electrophile sensor, Keap1.
This mechanism has been first unraveled for sulforaphane, an electrophile known for its
chemopreventive activation of phase II genes through conjugation to Keap1 [128]. Other
phytochemicals including curcumin from turmeric [129], diallyl sulfide from garlic [130],
and resveratrol from grapes [131], activate Nrf2 through direct conjugation with the reactive
cysteine of Keap1.
Remarkably, the same phenomenon has been observed for a series of nutritional polyphenols
usually referred to as ‘antioxidants’ only because they can react as chemical (free radical
scavenging) antioxidants in a test tube. The difference with the former compounds is that the
polyphenols, including catechin and epicatechin from cocoa or green tea, carnosic acid from
rosemary, hydroxytyrosol from olive leaf, and delphinidin from pomegranates, activate
Keap1 upon oxidation [132–137]. As pointed out above, indeed, it is the quinone formed
rather than the O2·− and H2O2 that are likely the more effective electrophiles in
physiologically relevant Keap1 activation [138]. This seemingly paradoxical effect of
antioxidants directly or indirectly modifying Keap1, the sensor for electrophiles, has been
repeatedly reported in the past few years. Cumulatively the ortho or para hydroquinone
structure emerges as the chemical entity eventually leading to transcriptional activation of
genes coding for proteins involved in antioxidant protection and Nucleophilic Tone. Fig 3
illustrates the conversion of a representative dietary antioxidant, carnosic acid to a structure
containing an electrophilic α,β-usaturated carbonyl that is present in other representative
dietary antioxidants. Fig 3 also shows the Michael addition of a thiolate to electrophiles.
As the oxidation of a polyphenol to the hydroquinone or quinone appears to be critical to its
ability to activate Nrf2 through Keap1 conjugation, the question arises as to how the
oxidation occurs. One mechanism is the reaction of the polyphenol with a free radical. Of
course, we have spent much time explaining how the elimination of free radicals by
scavenging cannot account for the action of polyphenols; however, that is because the
concentration of the polyphenols can never be sufficient in vivo to remove a significant
portion of the free radicals; i.e, it is not the reactivity but the physiological concentration that
is the limitation. On the other hand, polyphenols will be oxidized to electrophilic
hydroquinones and quinones during their reaction with free radicals.
Even at low concentrations, quinones are able to activate Keap1. Unlike the competition
between polyphenols and enzymes for removal of O2·− and hydroperoxides, the competition
here between reaction with Keap1 and enzymatic removal of electrophiles can favor the
former. This is because the glutathione S-transferases (GSTs) that remove electrophiles have
slow rates of catalysis. An example the second order rate constant for reaction of 1,4-
naphthoquinone with a generic thiolate is ~ 6.9 × 104 M−1 s−1 [139] which is reasonably
rapid compared to GST reaction rates for most substrates where kcat/KM varies from ~1 to
75 × 104 M−1 s−1 with some exceptions for extremely electrophilic compounds [140].
Indeed, the non-enzymatic conjugation of GSH to GST substrates can be more rapid at the
high intracellular GSH concentration than is the GST catalyzed rate [141]. Furthermore,
GSTs can be inhibited by quinones and their GSH-conjugates [142, 143].
In summary, we have discussed several issues regarding the physiological mechanisms of
action of nutritional antioxidants. Some of these reiterate what several colleagues have
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pointed out while others are either more obscure or novel. 1). What we hope is achieved by
this exercise is a synthesis of these ideas so that the value and limitations of nutritional
antioxidants are put into perspective. 2). The measured antioxidant capacity of
phytochemicals is simply an index of sensitivity to oxidation rather than an index of
protection that these agents can produce in vivo. 3). The principal manner by which
nutritional antioxidants act is Nrf2 activation through modification of a specific cysteine in
Keap1. 4). This modification of Keap1 requires that the antioxidant be, or be converted to,
an electrophile. 5). The consensus chemistry underlying Keap1 modification is Michael
addition, which is the reductive addition of a nucleophile (the specifically reactive Keap1
cysteine) to an 3,3-unsaturated carbonyl compound (the active form of the antioxidant).
Addition to an isothiocyanate, such as sulforaphane is also a reductive addition reaction. 6).
‘Adequate’ nutritional intake of antioxidants (obviously a controversial subject) provides an
adjustable level of nucleophiles that can be regulated to cope with increased electrophiles
including oxidants.
From the above chemical, biological, nutritional and epidemiological considerations we
propose two new terms. First, we suggest the term, ‘Nucleophilic Tone’ to describe the
cellular, tissue, organ, or even organismal level of protection against electrophiles (including
many free radicals and/or oxidants) by nucleophiles. Second, we propose the name ‘Para-
Hormesis’ to describe the process by which non toxic compounds maintain an adaptive and
defense system by mimicking electrophiles and increasing the Nucleophilic Tone; i.e., a
hormetic-like response that does not necessarily require an activating or initiating stress
(remembering that hormesis refers to the positive adaptational effects of low-dose toxins,
toxicants or other stressors). We suggest that the concepts of ‘Nucleophilic Tone and ‘Para-
Hormesis’ represent a paradigm shift in our understanding of the physiological mechanisms
of action of nutritional antioxidants, from free radical scavengers to stimuli for the
regulation of protective defense and repair systems.
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Assumptions of free radical scavenging by antioxidants in vivo are kinetically
unsound.
Among natural antioxidants, only vitamin E has the potential to act in vivo.
Electrophilic antioxidants and electrophiles derived from polyphenols increase
Nucleophilic Tone.
Nucleophilic Tone is the overall potential cellular adaptive response to oxidative
challenge brought by electrophiles.
Electrophiles induce Nucleophilic Tone through activation of Nrf2.
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Oxidation. Nucleophile give electrons in two electron (blue curved arrows) or one electron
(red curved arrows) reactions without forming an adduct. Reductants (HA) are nucleophiles
that give one or two electrons to an oxidant (X), without forming an adduct. The transfer of
electrons in oxidations and reduction may involve a hydrogen atom (H·) in one-electron
reactions or a hydride (H:) in two electron reactions. Nucleophiles can also add to
electrophiles thereby forming covalent bonds in either electrophilic or nucleophilic addition
reactions.
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Keap1 reacts in a Michael addition with a polyphenol oxidized to the corresponding
orthoquinone (or paraquinone) form . The alkylation of Keap1 permits Nrf2 to escape
ubiquitinylation and degradation. As described in the text, phosphorylation is also required
for Nrf2 translocation to the nucleus and activation of transcription through EpRE.
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Michael addition. Some dietary antioxidants contain α,β-unsaturated carbonyls. Others are
oxidized to form the similar structures. The electrophilic α,β-unsaturated carbonyl or
isocyanate of sulforaphane can react in a Michael addition with the thiolate of the critical
cysteine of Keap1.
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